Page 76 nursing.elitecme.com Complete Your CE Test Online - Click Here 228. National Toxicology Program (NTP) (2014). Report on Carcinogens, Thirteenth Edition. Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service. Retrieved from http://ntp.niehs.nih.gov/pubhealth/roc/roc13/ on March 28, 2016. 229. Oeffinger KC, Fontham ET, Etzioni R, et al. (2015). Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update from the American Cancer Society. Journal of the American Medical Association, 314(15): 1599-614. 230. Oesterheld JR, Turpeinen M (2011). Cytochrome P450-Mediated Interactions. P 50-64. In A Martin, L Scahill, C Kratochvil (Eds). Pediatric Psychopharmacology. Oxford University Press, New York 53. 231. Oncology Nursing Society (2015). Draft Standards of Oncology Nursing Education: Generalist and Advanced Practice Levels 4th ed. Retrieved from https://www.ons.org/sites/default/files/Public%20 Comment%20Standards%20Nursing%20Education%204th%20Edition.pdf on March 22, 2016. 232. Oncology Nursing Society (n.d.). Emetogenic Risk of Chemotherapy and Biotherapy Agents. Retrieved from https://www.ons.org/sites/default/files/emetogenicity_tool.pdf on April 8, 2016. 234. Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE (2005). Noninvasive testing for colorectal cancer: A review. American Journal of Gastroenterology, 100(6): 1393-1403. 235. Pal T, Permuth-Wey J, Betts JA, et al. (2005). BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer, 104(12): 2807–2816. 236. Palmer B (2011). Sievert, Gray, Rem, and Rad (Slate.com). Retrieved from http://www.slate.com/ articles/news_and_politics/explainer/2011/03/sievert_gray_rem_and_rad.html on March 11, 2016. 238. Parsons A, Daley A, Begh R, Aveyard P (2010). Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. British Medical Journal, 340: b5569. 239. Phillips KA, Milne RL, Rookus MA, et al. (2013). Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology, 31(25): 3091-3099. 240. Piatek C, Akhtari M (2015). Thrombocytopenia: Optimizing Approaches in Cancer Patients. Oncology Journal [Internet]. Retrieved from http://www.cancernetwork.com/oncology-journal/ thrombocytopenia-optimizing-approaches-cancer-patients on April 9, 2016. 241. Planchard D (2016). Can an Acidic Beverage Reduce Interactions Between Proton Pump Inhibitors and Erlotinib? Journal of Clinical Oncology, doi: 10.1200/JCO.2015.66.3344JCO. (published online before print). 242. Pollitz K, Cox C, Lucia K, Keith K., Kaiser Family Foundation (2014). Medical Debt Among People with Health Insurance. Retrieved from http://kff.org/report-section/medical-debt-among-people- with-health-insurance-consequences-of-medical-debt/ on February 29, 2016. 243. Preston DS, Stern RS (1992). Nonmelanoma cancers of the skin. New England Journal of Medicine, 327(23): 1649-1662. 244. Puliafito A, Hufnagel L, Neveu P, Streichan S, Sigal A, Fygenson DK, Shraiman BI (2012) Collective and single cell behavior in epithelial contact inhibition. Proceedings of the National Academy of Sciences, 109(3): 739-44. 245. RadiologyInfo.org (2015). Radiation Dose in X-Ray and CT Exams. Retrieved from http://www. radiologyinfo.org/en/pdf/safety-xray.pdf on March 29, 2016. 246. Ransohoff DF (2009). How much does colonoscopy reduce colon cancer mortality? Annals of Internal Medicine 2009; 150(1):50-52. 247. Rechis R, Beckjord E, Mayer DK (2014). Cancer Survivorship Support. In MM Gullatte (Ed). (2014.) Clinical Guide to Antineoplastic Therapy: A chemotherapy handbook, 3rd ed. Pittsburgh, PA: Oncology Nursing Society pp 969-994. 248. Rehm J, Patra J, Popova S (2007). Alcohol drinking cessation and its effect on esophageal and head and neck cancers: a pooled analysis. International Journal of Cancer, 121(5): 1132-1137. 249. Roesser KA, Colligon S (2014). Symptom Management. Cancer Survivorship Support. In MM Gullatte (Ed). Clinical Guide to Antineoplastic Therapy: A chemotherapy handbook, 3rd ed. Pittsburgh, PA: Oncology Nursing Society pp. 757-822. 250. Ronco G, Dillner J, Elfström KM, et al. (2014). Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomized controlled trials. Lancet, 383(9916): 524-532. 251. Rothenberg ML, Meropol NJ, Poplin EA, Van Cutsem E, Wadler S (2001). Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. Journal of Clinical Oncology, 19(18): 3801-3807. 252. Rugg T, Saunders MI, Dische S (1990). Smoking and mucosal reactions to radiotherapy. British Journal of Radiology, 63(751): 554-556. 253. Sarvaiya PJ, Guo D, Ulasov I, Gabikian P,Lesniak MS (2013). Chemokines in tumor progression and metastasis. Oncotarget 4(12): 2171-2185. 254. Saslow D, Solomon D, Lawson HW, et al. (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin, 62(3): 147- 172. 255. Schoen RE, Pinsky PF, Weissfeld JL, et al. (2012). Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. New England Journal of Medicine, 366(25): 2345-2357. 256. Skin Cancer Foundation (2016). Skin Types and At-Risk Groups. Retrieved from http://www. skincancer.org/prevention/are-you-at-risk/skin-types-and-at-risk-groups on March 30, 2016. 257. Skin Cancer Foundation (2013). UVA and UVB. Retrieved from http://www.skincancer.org/ prevention/uva-and-uvb/understanding-uva-and-uvb on May 16, 2016. 258. Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, Berrington de Gonzalez A, Miglioretti DL (2009). Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Archives of Internal Medicine, 169(22): 2078-2086. 259. Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, Brawley OW, Wender R (2015) Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Journal for Cancer Clinicians, 65(1):30-54. 260. Soni, A (2014). Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey. Statistical Brief #443: Trends in Use and Expenditures for Cancer Treatment among Adults 18 and Older, US Civilian Noninstitutionalized Population, 2001 and 2011. Retrieved from http://meps. ahrq.gov/mepsweb/data_files/publications/st443/stat443.shtml on February 29, 2016. 261. Soost HJ, Lange HJ, Lehmacher W, Ruffing-Kullmann B (1991). The validation of cervical cytology. Sensitivity, specificity and predictive values. Acta Cytologica, 35(1): 8-14. 262. Spurgeon ME, Lambert PF (2013). Merkel cell polyomavirus: a newly discovered human virus with oncogenic potential. Virology. 435(1): 118-30. 263. Stepanov I, Biener L, Yershova K, Nyman AL, Bliss R, Parascandola M, Hatsukami DK (2014). Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch. Nicotine & Tobacco Research, 16(8): 1070-1078. 264. Storm C, Casillas J, Grunwald H, Howard DS, McNiff K, Neuss MM (2008). Informed Consent for Chemotherapy: ASCO Member Resources. Journal of Oncology Practice, 4(6): 289-295. 265. Sultan K (2015). Neutropenic Enterocolitis. Retrieved from http://emedicine.medscape.com/ article/183791-overview on April 10, 2016. 266. Surget S, Khoury MP, Bourdon JC (2013). Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. OncoTargets and Therapy, 7: 57–68. 267. Tai YC, Domchek S, Parmigiani G, Chen S (2007). Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute, 99(23): 1811–1814. 268. Takeda Y, Kobayashi K, Akiyama Y, Soma T, Handa S, Kudoh S, Kudo K (2001). Prevention of irinotecan (CPT-11)-induced diarrhea by oral alkalization combined with control of defecation in cancer patients. International Journal of Cancer, 92(2): 269-275. 269. University of Pittsburgh Medical Center (UPMC) (2013). Radiopharmaceuticals for pain relief from metastatic bone disease. Retrieved from http://www.upmc.com/patients-visitors/education/cancer- radiation/Pages/radiopharmaceuticals-pain-relief.aspx on April 7, 2016. 270. United States Administration on Aging (2013). Aging Statistics. Retrieved from http://www.aoa.acl. gov/aging_statistics/index.aspx on February 25, 2016. 271. United States Administration on Aging (2013). Projected Future Growth of the Older Population, By State: 2005-2030. Retrieved from http://www.aoa.acl.gov/aging_statistics/future_growth/future_ growth.aspx#aging on February 25, 2016. 272. United States Administration on Aging (2013). The Next Four Decades: The Older Population in the United States 2010 to 2050. Retrieved from http://www.aoa.acl.gov/aging_statistics/future_growth/ DOCS/p25-1138.pdf on February 25, 2016. 273. United States Department of Health and Human Services (2013). Agency for Healthcare Research and Quality, Medical Expenditure Panel Survey. Number of People with Care for Selected Conditions by Type of Service: United States, 2013. Generated interactively from http://meps. ahrq.gov/mepsweb/data_stats/tables_compendia_hh_interactive.jsp?_SERVICE=MEPSSocket0&_ PROGRAM=MEPSPGM.TC.SAS&File=HC2Y2013&Table=HC2Y2013_CNDXP_A&_Debug= on March 22, 2016. 274. United States Department of Health and Human Services. Healthcare.gov Glossary. (n.d.) Special Enrollment Period. Retrieved from https://www.healthcare.gov/glossary/special-enrollment-period/ on February 29, 2016. 275. United States Department of Health and Human Services (2010). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK53017/pdf/ Bookshelf_NBK53017.pdf on April 15, 2016. 276. United States Department of Health and Human Services (n.d.). If you lose job-based health insurance. Retrieved from https://www.healthcare.gov/have-job-based-coverage/if-you-lose-job- based-coverage/ on Feb 29, 2016. 277. United States Department of Health and Human Services (2014). The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General, 2014. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Retrieved from http://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf on April 15, 2016. 278. United States Department of Labor (1998). Occupational Safety and Health Standards. Medical and First Aid. Retrieved from http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_ table=STANDARDS&p_id=9806 on March 18, 2016. 279. United States Department of Labor (n.d.). Work Changes Require Health Choices…Protect Your Rights. (Unstated date.) Retrieved from http://www.dol.gov/ebsa/publications/work_changes.html on February 29, 2016. 280. United States Environmental Protection Agency (2014). About Radiation in tobacco. Retrieved from https://www3.epa.gov/radtown/tobacco.html on March 28, 2016. 281. United States Food and Drug Administration (2015). FDA 101: Dietary Supplements. Retrieved from http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm050803.htm on March 30, 2016. 282. United States Nuclear Regulatory Commission (2015). Backgrounder on Biological Effects of Radiation. Retrieved from http://www.nrc.gov/reading-rm/doc-collections/fact-sheets/bio-effects- radiation.html on March 29, 2016. 283. United States Preventive Services Task Force (2016). About the USPSTF. Retrieved from http:// www.uspreventiveservicestaskforce.org/Page/Name/about-the-uspstf on March 9, 2016. 284. United States Preventive Services Task Force (2008). Clinical Summary of Colorectal Cancer: Screening. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/Document/ ClinicalSummaryFinal/colorectal-cancer-screening on March 7, 2016. 285. United States Preventive Services Task Force (2014). Discussion, Final Recommendation Statement: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication. Retrieved from http:// www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/aspirin- nsaids-for-prevention-of-colorectal-cancer-preventive-medication#discussion on March 9, 2016. 288. United States Preventive Services Task Force (2015). Draft Update Summary: Prostate Cancer: Screening. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/Document/ UpdateSummaryDraft/prostate-cancer-screening1 on March 3, 2016. 290. United States Preventive Services Task Force (2015). Final Recommendation Statement Cervical Cancer: Screening March 2012. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/ Document/RecommendationStatementFinal/cervical-cancer-screening on March 10, 2016. 291. United States Preventive Services Task Force (2014). Final Recommendation Statement: Colorectal Cancer: Screening. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/Document/ RecommendationStatementFinal/colorectal-cancer-screening on March 14, 2016. 292. United States Preventive Services Task Force (2016). Final Research Plan: Ovarian Cancer: Screening. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/Document/final- research-plan153/ovarian-cancer-screening1 on March 3, 2016. 293. United States Preventive Services Task Force (2016) Final Update Summary: Breast Cancer: Screening. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/Document/ UpdateSummaryFinal/breast-cancer-screening1?ds=1&s= on March 8, 2016 294. United States Preventive Services Task Force (2015). Final Update Summary: Prostate Cancer: Screening. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/Document/ UpdateSummaryFinal/prostate-cancer-screening?ds=1&s=Prostate on March 3, 2016. 295. United States Preventive Services Task Force (2013). Lung Cancer Screening Recommendation Summary. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/Document/ UpdateSummaryFinal/lung-cancer-screening on March 7, 2016. 296. United States Preventive Services Task Force (2012). Prostate Cancer Screening. Retrieved from http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/prostate- cancer-screening on April 14, 2016. 297. United States Preventive Services Task Force (2013). Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Clinical Summary of USPSTF Recommendation. AHRQ Publication No. 12-05164-EF-3. Retrieved from http://www. uspreventiveservicestaskforce.org/uspstf12/brcatest/brcatestsumm.htm on March 14, 2016. 298. Wadler S, Benson AB, Engelking C, et al. (1998). Recommended guidelines for the treatment of chemotherapy-induced diarrhea. Journal of Clinical Oncology, 16(9): 3169-3178. 299. Warren GW, Cummings KM (2013). Tobacco and lung cancer: risks, trends, and outcomes in patients with cancer. American Society of Clinical Oncology Education Book. 2013: 359-64. 300. Warren JL, Klabunde CN, Mariotto AB, Meekins A, Topor M, Brown ML, Ransohoff DF. (2009). Adverse events after outpatient colonoscopy in the Medicare population. Annals of Internal Medicine, 150(12): 849-857. 301. WebMD/Healthwise (2014). Ultraviolet Rays from the Sun – Topic Overview. Retrieved from http:// www.webmd.com/skin-problems-and-treatments/tc/ultraviolet-rays-from-the-sun-topic-overview on April 4, 2016. 302. Welch HG Black WC (2010). Overdiagnosis in Cancer. Journal of the National Cancer Institute, 102(9): 605-613.